- CEO
- Charles Victor Magro
- Full Time Employees
- 22,000
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Address
- 9330 Zionsville Road Indianapolis IN United States of America 46268
- IPO Date
- Nov 7, 1972
- Business
- EIDP, Inc. (NYSE: CTA-PA), a wholly owned subsidiary of Corteva, Inc. headquartered in Wilmington, Delaware and founded in 1915 as E. I. du Pont de Nemours and Company, operates as a global provider of seed and crop protection solutions for the agriculture industry; the company develops and supplies commercial seeds that combine advanced germplasm and traits for high-yield corn, soybeans, and other row crops, trait technologies enhancing resistance to weather, diseases, insects, and nutritional qualities, herbicides for weed control, insecticides, nitrogen stabilizers, pasture and range management products, biologicals, and digital farming solutions to optimize yields and profitability; its Seed segment targets farmers worldwide with superior genetics, while the Crop Protection segment delivers products safeguarding crops against pests, diseases, and nutrient loss above and below ground, serving markets in the United States, Canada, Europe, Latin America, Asia-Pacific, and other regions with approximately 21,000 employees and trailing twelve-month revenue of $17.74 billion. In October 2025, parent company Corteva announced plans to separate into two independent public companies by the second half of 2026, with EIDP expected to remain integral to the Crop Protection-focused entity emphasizing biologicals, operational excellence, and innovative solutions amid ongoing restructuring of its manufacturing network projected to conclude in 2026; earlier in May 2025, EIDP priced a $500 million senior notes offering due 2032 to refinance existing debt, launched over 2,500 new seed and crop protection products since 2019 supported by $8.9 billion in cumulative R&D, and reaffirmed full-year 2025 guidance with raised net sales expectations of $17.6 billion to $17.8 billion following strong quarterly results.